EXHIBIT 99.27
Hydromer, Inc. and Fossa Medical Enter Into a
One Year Stand Still Agreement
BRANCHBURG, N.J.--(BUSINESS WIRE)--May 31, 2007--Hydromer, Inc.
(HYDI.OB - OTC BB; HDO - BSE) and Fossa Medical (a Boston based
medical device developer with patented innovative technologies for
removing obstructions and restoring patency of the urinary systems)
have entered into a 1 year Stand Still Agreement.
Under terms of this agreement, Hydromer has agreed to provide
Fossa Medical exclusive access to the new Hydromer Antimicrobial
Coatings for use on ureteral stents. During the term of this one year
agreement Fossa Medical will continue with the testing and development
of their new Hydromer(R) coated Open-8(TM) Urinary Stent. The Hydromer
antimicrobial coating functions without the use of leaching active
ingredients, and thus continues to have long term performance against
bacterial colonization.
According to Xxxxxx Xxxx, President of Fossa Medical, "In an in
vitro flow study with ureteral stents, two different bacteria were
released into the system to facilitate encrustation and blockage, a
common in vivo problem. In the absence of bacteria, flow rates were
similar. However, following bacterial incubation, flow rates for the
antimicrobial-coated stents were 34% faster than regular
hydrophilic-coated stents and 68% faster than uncoated stents."
Xxxxxx Xxxx added that Fossa Medical has also confirmed the
biocompatibility of the Hydromer coated stents, via the successful
completion of a formal biological test protocol as performed by a
major American test laboratory. "Based on the passing of all four in
vivo biocompatibility testing, including the 13-week implant with
histology test, the Open-8 device with Hydromer's Antimicrobial
Coating is biocompatible."
"This is a very exciting medical application for our new
antimicrobial coating technology," commented Xxxxxx xxx Xxxx,
Executive Vice President of Hydromer, Inc., adding, "In addition to
working with an innovative company like Fossa Medical, our
antimicrobial coatings are also being evaluated by various other
medical device companies for possible use on their catheters and
device applications."
For additional information please visit the following Web-sites:
xxx.xxxxxxxx.xxx
xxx.xxxxxxxxxxxx.xxx
Hydromer, Inc. is a technology-based company involved in the
research and development, manufacture and commercialization of
specialized polymer and hydrogel products for medical device,
pharmaceutical, animal health, cosmetic, personal care, and industrial
uses. For the latest information about Hydromer, Inc. and its
products, please visit our web site at xxxx://xxx.xxxxxxxx.xxx.
CONTACT: Hydromer, Inc.
Xxxxxx X. Xxxx, 908-722-5000
Executive Vice President
